SCHEMBL4930685

SCHEMBL4930685

Cc1cc(COc2c(Cl)cc(CC(F)C(=O)O)cc2Cl)cc(NC2CCC2)c1

nearest known ligand 0.37

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 4/20 0.37
MEN1 O00255 2/20 0.37
FFAR1 O14842 2/20 0.36
ALDH1A1 P00352 2/20 0.35
KDM4E B2RXH2 2/20 0.35
OPRK1 P41145 1/20 0.35
HTT P42858 2/20 0.34
MAPT P10636 1/20 0.34
NPSR1 Q6W5P4 1/20 0.34
PTGS1 P23219 1/20 0.33
PTGS2 P35354 1/20 0.33
TACR1 P25103 1/20 0.33
MRGPRX4 Q96LA9 3/20 0.33
S1PR1 P21453 2/20 0.32
NPC1 O15118 1/20 0.32
RAB9A P51151 1/20 0.32
SMN1; SMN2 Q16637 1/20 0.32
GAA P10253 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4933385 0.90 MEN1 (0.39) KMT2AMEN1FFAR1ALDH1A1KDM4E
SCHEMBL4929570 0.90 FFAR1 (0.35) KMT2AMEN1FFAR1ALDH1A1KDM4E
SCHEMBL5718054 0.88 MEN1 (0.38) KMT2AMEN1FFAR1ALDH1A1KDM4E
SCHEMBL5718015 0.87 MEN1 (0.36) KMT2AMEN1FFAR1TACR1MRGPRX4
SCHEMBL4932565 0.87 MRGPRX4 (0.41) TACR1MRGPRX4S1PR1
SCHEMBL4934576 0.85 KMT2A (0.40) KMT2AMEN1ALDH1A1KDM4EOPRK1
SCHEMBL4935426 0.85 FFAR1 (0.39) KMT2AMEN1FFAR1ALDH1A1HTT
SCHEMBL4931768 0.84 FFAR1 (0.40) KMT2AFFAR1ALDH1A1KDM4EMAPT
SCHEMBL4931110 0.84 CRHR1 (0.36) FFAR1TACR1MRGPRX4S1PR1
SCHEMBL4531944 0.83 THRA (0.45) KMT2AMEN1FFAR1ALDH1A1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080221210-A1 Thyroid Receptor Agonists KARO BIO AB (SE) 2008-09-11 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080221210-A1 Thyroid Receptor Agonists TSHR, TRHR, THRA KMT2A 1742/4885MEN1 773/4885FFAR1 37/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.